Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Prof Adrian Harris (Department of Oncology), who has become a Fellow of the Association of Cancer Physicians.

Professor Harris was awarded the honour of Fellowship of the Association of Cancer Physicians (FACP) for outstanding contributions to the development of medical oncology and cancer research.

Adrian Harris portraitThis is awarded based on translational research, particularly breast cancer and pathways of hypoxia, angiogenesis and endocrine regulation of growth. He also established two departments of medical oncology, the first time in Newcastle upon Tyne in 1982 and then one in Oxford in 1989. In both, he established phase I units as part of a CRUK national programme, with a particular emphasis on pharmacodynamics and sampling of tumours during studies, to help direct therapies. He took a major role in developing antiangiogenic therapy and investigating new pathways that could mediate resistance to current drugs.

He has trained over 50 DPhil students in medical oncology, clinical and cancer therapy. He also was involved in the early development of genetic classification of breast cancer and many refinements based on new discoveries of the interactions with angiogenesis and hypoxia biology.

Similar stories

MP Anneliese Dodds tours Oxford cancer research

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.

Dr Lennard Lee awarded ACP McElwain Prize for contributions to medical oncology

Dr Lee (Department of Oncology) received the award to acknowledge his contributions during the COVID-19 pandemic, through the establishment of the UK Coronavirus Cancer Monitoring Project.

Professor Sibson secures further MRC DPFS funding

Prof. Sibson together with her co-applicants Prof. Anthony, Dr Campbell and Prof. Middleton have now been awarded a second MRC DPFS grant, for £3.3 million, to acquire further preclinical data to support the case for clinical translation, to develop the mutTNF production for human use and to undertake pre-clinical toxicology.

Vice-Chancellor's Innovation Awards 2020

Congratulations to Professor Anna Schuh and her team who are the Winners of the Teamwork category in the Vice-Chancellor Innovation Awards 2020 for their work on SEREN_A Social Enterprise to deliver DNA-based diagnostics that improves outcomes of children and young adults with blood diseases in sub-Saharan Africa.